Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Dr. Areej El-Jawahri on the Impact of Palliative Care

September 1st 2016

Psychological Effects From ADT a Growing Challenge in Prostate Cancer

August 22nd 2016

Heather Jim, MD, describes the psychological impacts of testosterone-lowering drugs for patients with prostate cancer—and what oncologists should do to help.

Studies Confirm Rolapitant Reduces CINV in Breast and Gynecologic Cancers

August 18th 2016

Additional findings from 2 studies of rolapitant (Varubi) for the prevention of CINV are providing further evidence of the efficacy of the long-acting NK-1 receptor antagonist.

Dr. Hudis on Combating Obesity in Breast Cancer

August 18th 2016

Clifford A. Hudis, MD, CEO, ASCO, discusses how oncologists should be helping patients with breast cancer overcome obesity.

Patient Resistance to Swallowing Exercises After Multimodality Therapy

August 17th 2016

Giselle Carnaby, PhD, professor, ASHA fellow, Communication Sciences and Disorders, University of Central Florida, discusses rehabilitation of swallowing after multimodality therapy in patients with head and neck cancer, and why they may be resistant to it.

FDA Approves Extended-Release Granisetron for CINV

August 10th 2016

The FDA has approved an extended release injection formulation of granisetron (Sustol) for use in combination with other antiemetic therapies for the prevention of chemotherapy-induced nausea and vomiting.

Tough Target: New Therapies for Cancer Pain Lagging

August 5th 2016

Despite a leap forward in our understanding of the molecular mechanisms of cancer pain in the past several decades, clinical translation of targeted therapies has been slow.

NYU Expert Says Cancer Pain Varies by Tumor Type

August 5th 2016

Brian L. Schmidt, DDS, MD, PhD, discusses the difficulties of studying cancer pain and developing new drugs.

FDA Approves Dronabinol Solution to Treat CINV

August 3rd 2016

A dronabinol oral solution (Syndros) has been approved by the FDA as a treatment for patients with chemotherapy-induced nausea and vomiting (CINV) in those who have not responded to conventional antiemetic therapies.

Dr. El-Jawahri on Early Integrated Palliative Care in Patients With Lung or GI Cancer

July 29th 2016

Areej R. El-Jawahri, MD, assistant in Medicine, Massachusetts General Hospital, instructor in Medicine, Harvard Medical School, discusses a study examining early integrated palliative care for patients with gastrointestinal (GI) or lung cancer and the impact it has on family caregiver outcomes.

Optimizing Care to Avoid CINV

July 26th 2016

Emerging Approaches in CINV

July 26th 2016

Options in Breakthrough Nausea and Vomiting

July 26th 2016

Unmet Needs in CINV Treatment

July 26th 2016

Emesis Potential of Newer Anti-Cancer Therapies

July 26th 2016

Understanding the Guidelines for Anti-Emetics in CINV

July 26th 2016

CINV: Newer Options for Prophylaxis and Treatment

July 26th 2016

CINV: The Role of NK1 Receptor Antagonists

July 26th 2016

Managing Side Effects with Antiemetics

July 26th 2016

Optimal Use of 5-HT3 Antagonists in CINV

July 26th 2016